alisporivir

Novartis drops out of hep C race, punting a $440M Enanta pact
Fierce Biotech
Wed, 10/1/14 - 09:19 am
Novartis
hepatitis C
Enanta Pharmaceuticals
EDP-239
alisporivir
Novartis halts hepatitis drug trial after death
Bloomberg Businessweek
Fri, 04/20/12 - 11:05 am
hepatitis C
Novartis
alisporivir